Reply  by Byrne, John G.
The discussion addresses the risks of transfusions, reoperations
for bleeding, and bleeding during surgery following antiplatelet
therapy, but this study does not have the power or the design to
conclude so. This type of secondary analysis represents, from a
statistical standpoint, a “fishing expedition” for significant results.
In summary, although the concept of hybrid treatment may
have some merit, the major biases and methodological flaws forgo
the possibility of establishing valuable conclusions. Until proven
otherwise with properly designed prospective controlled studies,
surgical myocardial revascularization remains the gold standard for
patients with combined coronary and valvular heart disease. The
data presented in the study by Byrne et al. (1) do not support
modification of our current treatment strategy in favor of the
hybrid approach.
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REPLY
In reply the comments of Dr. Perrault and colleagues, our study
group (n  26) was a very high-risk group, with multiple
co-morbidities all requiring emergent or urgent procedures (1).
The predicted operative mortality, had emergency coronary artery
bypass graft (CABG) valve surgery been performed at the time of
percutaneous coronary intervention (PCI), was20%. All patients
presented with acute coronary syndromes; many had low cardiac
output or shock and nearly half were reoperations. By stabilizing
the patients with PCI to the culprit vessels, we were able to lower
the observed operative mortality to about 4%. The benefit to the
patients in our study was not just minimizing the surgical trauma
(concomitant CABG was not needed in any patient requiring
reoperation) but also the benefit of time to allow for improved
patient status. We acknowledge that some patients who underwent
emergency PCI to a culprit vessel, who had known valve disease,
may not have been offered surgery during their hospitalization
because they did not improve to the level deemed operable, or were
deemed too stable and sent home for later elective valve surgery.
Although statistical analysis is not possible, as described in our
study, most clinicians would agree that the observations in this
study have meaningful clinical benefit.
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